Post by AbbVie on X
AbbVie@abbvie
XWe've signed a definitive agreement to acquire Apogee Therapeutics. The proposed acquisition will deepen our #immunology portfolio with differentiated assets focused on dermatologic, respiratory and other related inflammatory diseases. Learn more: t.co
15 likes2 repliesPosted Jun 22, 2026